Literature DB >> 8048831

Neurological crisis in hereditary tyrosinaemia and complete reversal after liver transplantation.

G Noble-Jamieson1, N Jamieson, P Clayton, S Bailey, M Ryalls, N D Barnes.   

Abstract

A 19 month old Indian girl with tyrosinaemia developed a severe generalised neuropathy involving both phrenic nerves. Treatment with haemarginate failed to improve her condition. After liver transplantation the raised concentrations of the neurotoxin delta amino-laevulinic acid returned to normal and gradual but complete neurological recovery occurred over a period of 13 months.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8048831      PMCID: PMC1029882          DOI: 10.1136/adc.70.6.544

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  3 in total

1.  Hematin therapy for the neurologic crisis of tyrosinemia.

Authors:  J M Rank; A Pascual-Leone; W Payne; M Glock; D Freese; H Sharp; J R Bloomer
Journal:  J Pediatr       Date:  1991-01       Impact factor: 4.406

2.  Neurologic crises in hereditary tyrosinemia.

Authors:  G Mitchell; J Larochelle; M Lambert; J Michaud; A Grenier; H Ogier; M Gauthier; J Lacroix; M Vanasse; A Larbrisseau
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

3.  Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.

Authors:  S Lindstedt; E Holme; E A Lock; O Hjalmarson; B Strandvik
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

  3 in total
  4 in total

1.  Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice.

Authors:  Megan A Hillgartner; Sarah B Coker; Ashton E Koenig; Marissa E Moore; Elizabeth Barnby; Gordon G MacGregor
Journal:  J Inherit Metab Dis       Date:  2016-06-06       Impact factor: 4.982

2.  Tyrosinemia type I: Case series with response to treatment to NTBC.

Authors:  Ira Shah; Forum Shah
Journal:  Indian J Gastroenterol       Date:  2016-04-25

3.  Tyrosinemia type 1 and irreversible neurologic crisis after one month discontinuation of nitisone.

Authors:  Neslihan Önenli Mungan; Dinçer Yıldızdaş; Deniz Kör; Özden Özgür Horoz; Faruk İncecik; Murat Öktem; Johannes Sander
Journal:  Metab Brain Dis       Date:  2016-05-17       Impact factor: 3.584

4.  Clinical and para clinical findings in the children with tyrosinemia referring for liver transplantation.

Authors:  Seyed Mohsen Dehghani; Mahmood Haghighat; Mohammad Hadi Imanieh; Hossein Karamnejad; Abdorrasoul Malekpour
Journal:  Int J Prev Med       Date:  2013-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.